Siwele Bakani A, Makhado Ndivhuho A, Mariba Matodzi T
Department of Orthopaedics, Sefako Makgatho Health Science University, Pretoria, South Africa.
National Health Laboratory Service - Dr George Mukhari Tertiary Laboratory, Department of Medical Microbiology, Pretoria, South Africa.
Afr J Lab Med. 2019 Jul 29;8(1):783. doi: 10.4102/ajlm.v8i1.783. eCollection 2019.
South Africa has one of the top ten tuberculosis burdens in the world, only lagging behind countries with significantly larger populations. Increased awareness of extrapulmonary tuberculosis, specifically spinal tuberculosis, is necessary, because of the HIV epidemic.
This report describes the case of a 9-year-old male patient who was suspected of having multidrug-resistant (MDR) tuberculosis, based on failure to recover clinically and radiologically after 6 months on first-line anti-tuberculosis treatment. Pus samples were sent to an accredited academic laboratory for histopathology, microscopy, culture, line-probe assay (MTBDR assay) and phenotypic MGIT 960 drug susceptibility tests. Second-line MDR tuberculosis treatment was introduced. Clinical, radiological, physical processes and more laboratory tests were conducted to document whether or not there was improvement in the patient.
After laboratory diagnosis of MDR tuberculosis, the patient was started on MDR tuberculosis treatment. The patient started improving remarkably after the introduction of anti-tuberculosis treatment and rehabilitation, although he also required surgery to stabilise the spine. Neurological improvement was observed in the patient and he fully recovered.
Although the diagnosis of spinal MDR tuberculosis may not be achieved easily by culture, the well-known gold standard method of tuberculosis diagnosis, it is of great importance to rapidly initiate an effective anti-tuberculosis treatment of drug-resistant strains to reduce the deformity of the spine.
南非是全球结核病负担最为严重的十个国家之一,仅落后于人口规模大得多的国家。鉴于艾滋病的流行,提高对肺外结核病,特别是脊柱结核的认识很有必要。
本报告描述了一名9岁男性患者的病例,该患者在接受一线抗结核治疗6个月后,临床和影像学上均未恢复,怀疑患有耐多药(MDR)结核病。脓样本被送往一家经认可的学术实验室进行组织病理学、显微镜检查、培养、线性探针分析(MTBDR分析)和表型MGIT 960药敏试验。开始了二线耐多药结核病治疗。进行了临床、影像学、身体检查及更多实验室检查,以记录患者是否有所改善。
在实验室诊断为耐多药结核病后,该患者开始接受耐多药结核病治疗。在开始抗结核治疗和康复后,患者病情显著改善,不过他还需要进行手术来稳定脊柱。患者的神经功能得到改善并完全康复。
尽管通过培养这种众所周知的结核病诊断金标准方法可能不容易实现脊柱耐多药结核病的诊断,但迅速启动针对耐药菌株的有效抗结核治疗以减少脊柱畸形非常重要。